Merus NV (MRUS) is around the top of the Biotechnology industry according to InvestorsObserver. MRUS received an overall rating of 78, which means that it scores higher than 78 percent of all stocks. Merus NV also achieved a score of 95 in the Biotechnology industry, putting it above 95 percent of Biotechnology stocks. Biotechnology is ranked 48 out of the 148 industries.
MRUS has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on MRUS!
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Merus NV Stock Today?
Merus NV (MRUS) stock has gained 5.87% while the S&P 500 is down -0.16% as of 1:38 PM on Thursday, Nov 30. MRUS is up $1.39 from the previous closing price of $23.58 on volume of 346,637 shares. Over the past year the S&P 500 is higher by 11.36% while MRUS is up 62.67%. MRUS lost -$3.72 per share the over the last 12 months.
Click Here to get the full Stock Report for Merus NV stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
